Predictive performance of serum digoxin concentration in patients with congestive heart failure by a hyperbolic model based on creatinine clearance

被引:21
作者
Konishi, H [1 ]
Shimizu, S
Chiba, M
Minouchi, T
Koida, M
Yamaji, A
机构
[1] Shiga Univ Med Sci, Dept Hosp Pharm, Otsu, Shiga 5202192, Japan
[2] Setsunan Univ, Fac Pharmaceut Sci, Dept Pharmacol, Hirakata, Osaka 57301, Japan
关键词
congestive heart failure; creatinine clearance; hyperbolic prediction model; serum digoxin concentration;
D O I
10.1046/j.1365-2710.2002.00418.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: To formulate a simple equation for determining the daily dose requirements of digoxin by inclusion of creatinine clearance (Ccr) values as an explanatory variable. Methods: We included 235 routine monitoring and clinical laboratory test data (steady-state serum digoxin concentration and Ccr values), obtained from hospitalized patients receiving digoxin for treatment of congestive heart failure. The 107 data sets were fitted to a hyperbolic model to account for the relation between the ratio of serum digoxin level to the daily dose (L/D) and the Ccr values determined by six methods. Their correlation coefficients (r) were computed by non-linear regression analysis. To evaluate the validity of the best-fitting model, the predictive performance of the L/D ratios was compared with those given by seven reference models previously published, using another 128 data sets. Results: The hyperbolic model involving the Ccr values estimated by Cockcroft and Gault's equation showed the closest correlation (r = 0.81) between the actual and estimated Ccr values. Mean prediction error (ME), a measure of bias, of the L/D ratio (0.018 ng/mL) was almost negligible when other data were fitted to the proposed model, and this ME value proved to be much smaller than those calculated from the previously published prediction models. Mean absolute prediction error, a measure of precision, by the proposed model was also satisfactory for prediction. Conclusions: The newly developed model provided good predictive performance of serum digoxin level. Taking simplicity in practical use into account, the clinical application of the proposed model will allow for accurate and rapid determination of the initial maintenance dosing regimen of digoxin based on the individual Ccr value, without actual measurement of its serum concentration.
引用
收藏
页码:257 / 265
页数:9
相关论文
共 30 条
[1]   Mixed-effect modeling for detection and evaluation of drug interactions: Digoxin-quinidine and digoxin-verapamil combinations [J].
Bauer, LA ;
Horn, JR ;
Pettit, H .
THERAPEUTIC DRUG MONITORING, 1996, 18 (01) :46-52
[2]  
Cheng JWM, 1997, PHARMACOTHERAPY, V17, P584
[3]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[4]   THERAPEUTIC DRUG-MONITORING OF DIGOXIN - HELP OR HINDRANCE [J].
DOBBS, RJ ;
NICHOLSON, PW ;
DENHAM, MJ ;
DOBBS, SM ;
ONEILL, CJA .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (04) :491-495
[5]  
DOHERTY JE, 1973, S DIGITALIS, P168
[6]   PREDICTING GLOMERULAR FUNCTION FROM ADJUSTED SERUM CREATININE [J].
GAULT, MH ;
LONGERICH, LL ;
HARNETT, JD ;
WESOLOWSKI, C .
NEPHRON, 1992, 62 (03) :249-256
[7]  
Haji SA, 2000, AM FAM PHYSICIAN, V62, P409
[8]  
Hori R, 1994, JPN J THER DRUG MONI, V11, P7
[9]  
Horio M, 1996, Nihon Jinzo Gakkai Shi, V38, P296
[10]   INFLUENCE OF RANGE OF RENAL-FUNCTION AND LIVER-DISEASE ON PREDICTABILITY OF CREATININE CLEARANCE [J].
HULL, JH ;
HAK, LJ ;
KOCH, GG ;
WARGIN, WA ;
CHI, SL ;
MATTOCKS, AM .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (04) :516-521